Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream
Sponsor: LEO Pharma
Summary
This is a single-centre, randomised, vehicle-controlled, double-blind, within-subject comparison phase 1 clinical trial. The trial is designed to find out if delgocitinib cream can cause skin irritation after light exposure in people with healthy skin.
Official title: A Phase 1 Clinical Trial to Evaluate the Phototoxic Potential of Delgocitinib Cream After Single Topical Occlusive Application on Healthy Skin
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
35
Start Date
2020-04-23
Completion Date
2020-05-30
Last Updated
2026-04-28
Healthy Volunteers
Yes
Conditions
Interventions
Delgocitinib cream
Cream for topical application
Delgocitinib cream vehicle
The cream vehicle is similar to the delgocitinib cream except that it does not contain any active ingredient.
Locations (1)
Bioskin Research Center Dermatology
Hamburg, Germany